Buyer for full-service CRO in Europe

Company to buy

• Size: Medium 
• Sales: 10-30 million EUR
• Location: Europe
• Reason for acquisition: The management wants to expand their business
• #CFIE PHB189

Overview of the buyer for full-service CRO in Europe

The company is a full-service contract research organization (CRO) that operates globally. It focuses on the acceleration of drug research and medical device research. Further, it has an extensive history and accumulated expertise from providing quality services for almost three decades. Above all, the company operates in more than 30 research areas.

Profile (strategy) of buyer for full-service CRO in Europe

The company’s strategy is centered on being a full-service high-quality contract research organization. It provides agile, quality solutions to the pharmaceutical industry, the medical device industry, and to consumer product developers. Further, the company is widely recognized for its reputation as a facilitator of strict drug and device approval processes. Moreover, it has proven expertise in over 30 research areas.
Most importantly, the company is highly dedicated to adherence to timeframes, quality standards, and client relationships. It operates over the full product lifecycle of its clients. In addition, the company has a diverse client base across its specialized industries, ranging from small to large multinational corporations. Above all, it aims for long-term relationships with clients in a cooperative manner.
The company operates in the pharmaceutical, biotech, medical device, consumer healthcare, and cosmetics sectors. In particular, its pharmaceutical business is centered around pharmacology and toxicology. Further, its biotechnological business is focused on biometrics and statistics, providing clinical data management solutions with exceptional insight. In addition, the company also conducts medical device research, consumer product research, and provides drug safety solutions.

Activities and products of a suitable target

The target company should operate in the full-service contract research business. Likewise, it should be an organization with a strong track record in clinical research and correlated areas. The ideal target company is a medium-sized business in Europe with annual revenue of between 10 and 30 million euros.

Highlights

• Extensive history and track record of high-quality services and client satisfaction
• Proven expertise in more than 30 research areas
• Agile and quick service with a stellar rate of timeline fulfillment
• Dedicated staff with top-notch academic degrees from leading global universities
• Full-service contract research for all product lifecycle stages

More information on this buyer for full-service CRO in Europe

Please get in touch if you are interested in learning more about this buyer for full-service CRO in Europe. For more cro companies for sale please visit the section cro companies for sale. For other cro buyers, please visit the section cro companies wanted. If you are instead interested in pharma companies for sale, please visit the pharma companies for sale section. For pharma buyers, please visit the section pharma companies wanted.